Publications by authors named "K Foerster"

Claim this Profile
P
Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project.
Kirsten H Harvey, Eleni Korompoki, Emily R Harvey, Cornelia Fießler, Uwe Malzahn, Kathrin I Foerster

Thromb Haemost· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation.
Angela Elma Edwina, Lorenz Van der Linden, Louise Debruyne, Kathrin Foerster, Jürgen Burhenne

J Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Amiodarone on Apixaban Exposure in Patients after Cardiac Surgery-A Population Pharmacokinetic Study.
Benedict Morath, Kathrin I Foerster, Ute Chiriac, Marcin Zaradzki, Torsten Hoppe-Tichy

Clin Pharmacokinet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers.
Alexander Lenard, Simon A Hermann, Felicitas Stoll, Juergen Burhenne, Kathrin I Foerster

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
Roland Veltkamp, Eleni Korompoki, Kirsten H Harvey, Emily R Harvey, Cornelia Fießler, Kathrin I Foerster

Lancet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis